ILMN (Illumina Corp) יחס שווי שוק לשווי בספרים

This chart of the market-to-book ratio demonstrates the impact of NovaSeq X and the completion of the GRAIL transaction on Illumina, Inc. (ILMN) share prices, with 14.85 representing the current metric. Despite pressure from new technological players, Illumina, Inc. (ILMN) maintains a steady cash flow through the sale of DNA analysis equipment and consumables.

This ratio compares the business's market value to its net assets, determining the degree to which shares are overvalued relative to actual capital. By analyzing the ratio of the company's market capitalization to its book value, an investor assesses the stability of Illumina, Inc. (ILMN), whose monopoly on sequencers and customer reliance on consumables create high added value that often significantly exceeds the value of physical assets.